SCOPUS 정보 검색 플랫폼

Antimicrobial Agents and Chemotherapy

Volumn 51, Issue 10, 2007, Pages 3737-3739

Orally administered combined regimens for treatment of Mycobacterium ulcerans infection in mice

(5) Ji, Baohong a Chauffour, Aurélie a Robert, Jérôme a Lefrançois, Sébastien a Jarlier, Vincent a

a SORBONNE UNIVERSITÉ (France)

Author keywords

[No Author keywords available]

Indexed keywords

CLARITHROMYCIN; MOXIFLOXACIN; RIFAMPICIN; STREPTOMYCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERICIDAL ACTIVITY; BURULI ULCER; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; MONOTHERAPY; MOUSE; MYCOBACTERIOSIS; MYCOBACTERIUM ULCERANS; NONHUMAN; PRIORITY JOURNAL; TREATMENT OUTCOME;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTIBIOTICS, ANTITUBERCULAR; AZA COMPOUNDS; CLARITHROMYCIN; COLONY COUNT, MICROBIAL; DRUG COMBINATIONS; FEMALE; FOOT; MICE; MICE, INBRED BALB C; MYCOBACTERIUM INFECTIONS, ATYPICAL; MYCOBACTERIUM ULCERANS; QUINOLINES; RIFAMPIN; STREPTOMYCIN;

EID: 34948885085 PISSN: 00664804 EISSN: None Source Type: Journal
DOI: 10.1128/AAC.00730-07 Document Type: Article

Times cited : (48)

References (6)

1
- 35848932800
- Promising clinical efficacy of the combination streptomycin-rifampin for the treatment of Buruli ulcer (Mycobacterium ulcerans disease). Antimicrob
- 25 May, doi:10.1128/AAC.00175-07
- Chauty, A., M.-F. Ardant, A. Adeye, H. Euverte, A. Guedenon, C. Johnson, J. Aubry, E. Nuermberger, and J. Grosset. 25 May 2007. Promising clinical efficacy of the combination streptomycin-rifampin for the treatment of Buruli ulcer (Mycobacterium ulcerans disease). Antimicrob. Agents Chemother. doi:10.1128/AAC.00175-07.
- (2007) Agents Chemother
- Chauty, A.¹ Ardant, M.-F.² Adeye, A.³ Euverte, H.⁴ Guedenon, A.⁵ Johnson, C.⁶ Aubry, J.⁷ Nuermberger, E.⁸ Grosset, J.⁹

2
- 23044451316
- Efficacy of the combination of rifampin-streptomycin in preventing growth of Mycobacterium ulcerans in early lesions of Buruli ulcer in humans
- Etuaful, S., B. Carbonnelle, J. Grosset, S. Lucas, C. Horsfield, R. Phillips, M. Evans, D. Ofori-Adjei, E. Klustse, J. Owusu-Boateng, G. K. Amedofu, P. Awuah, E. Ampadu, G. Amofah, K. Asiedu, and M. Wansbrough-Jones. 2005. Efficacy of the combination of rifampin-streptomycin in preventing growth of Mycobacterium ulcerans in early lesions of Buruli ulcer in humans. Antimicrob. Agents Chemother. 49:3182-3186.
- (2005) Antimicrob. Agents Chemother , vol.49 , pp. 3182-3186
- Etuaful, S.¹ Carbonnelle, B.² Grosset, J.³ Lucas, S.⁴ Horsfield, C.⁵ Phillips, R.⁶ Evans, M.⁷ Ofori-Adjei, D.⁸ Klustse, E.⁹ Owusu-Boateng, J.¹⁰ Amedofu, G.K.¹¹ Awuah, P.¹² Ampadu, E.¹³ Amofah, G.¹⁴ Asiedu, K.¹⁵ Wansbrough-Jones, M.¹⁶

3
- 33744470095
- In vitro and in vivo activities of rifampin, streptomycin, amikacin, moxifloxacin, R207910, linezolid, and PA-824 against Mycobacterium ulcerans
- Ji, B., S. Lefrançois, J. Robert, A. Chauffeur, C. Truffot, and V. Jarlier. 2006. In vitro and in vivo activities of rifampin, streptomycin, amikacin, moxifloxacin, R207910, linezolid, and PA-824 against Mycobacterium ulcerans. Antimicrob. Agents Chemother. 50:1921-1926.
- (2006) Antimicrob. Agents Chemother , vol.50 , pp. 1921-1926
- Ji, B.¹ Lefrançois, S.² Robert, J.³ Chauffeur, A.⁴ Truffot, C.⁵ Jarlier, V.⁶

4
- 33846607261
- Curing Mycobacterium ulcerans infection in mice with combination of rifampin-streptomycin or rifampin-amikacin
- Lefrançois, S., J. Robert, A. Chauffeur, B. Ji, and V. Jarlier. 2007. Curing Mycobacterium ulcerans infection in mice with combination of rifampin-streptomycin or rifampin-amikacin. Antimicrob. Agents Chemother. 51:645-650.
- (2007) Antimicrob. Agents Chemother , vol.51 , pp. 645-650
- Lefrançois, S.¹ Robert, J.² Chauffeur, A.³ Ji, B.⁴ Jarlier, V.⁵

5
- 0037378042
- Isolation of three Mycobacterium ulcerans strains resistant to rifampin after experimental chemotherapy of mice
- Marsollier, L., N. Honoré, P. Legras, A. L. Manceau, H. Kouakou, B. Carbonnelle, and S. T. Cole. 2003. Isolation of three Mycobacterium ulcerans strains resistant to rifampin after experimental chemotherapy of mice. Antimicrob. Agents Chemother. 47:1228-1232.
- (2003) Antimicrob. Agents Chemother , vol.47 , pp. 1228-1232
- Marsollier, L.¹ Honoré, N.² Legras, P.³ Manceau, A.L.⁴ Kouakou, H.⁵ Carbonnelle, B.⁶ Cole, S.T.⁷

6
- 19344373725
- World Health Organization, World Health Organization, Geneva, Switzerland
- World Health Organization. 2004. Provisional guidance on the role of specific antibiotics in the management of Mycobacterium ulcerans disease (Buruli ulcer). World Health Organization, Geneva, Switzerland.
- (2004) Provisional guidance on the role of specific antibiotics in the management of Mycobacterium ulcerans disease (Buruli ulcer)

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.